Julie KLEIN
Works at
Institut des Maladies Métaboliques et Cardiovasculaires
Lead investigator
Sources: openalex.org
Grants and prizes
Agence Nationale de la Recherche
EP PerMed, Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes, ANR-24-EPPM-0001, 2025, 1 Apr 2025
Sources: openalex.org